NeuMe Neurotech Funding: First Cheque From IvyCap’s India Endowment Fund
NeuMe Neurotech, a Kozhikode startup building a brain-computer interface for stroke rehab, is the first investment from IvyCap's India Endowment Fund.

Quick Take
- NeuMe Neurotech, a Kozhikode startup building a brain-computer interface (BCI) headband for cognitive rehabilitation, is the first investment from IvyCap Ventures’ India Endowment Fund. The amount was not disclosed.
- The deal was presented at Huddle Global 2026 in Kovalam, where IvyCap founder Vikram Gupta handed the stage to NeuMe founder Aparna RVM.
- Next: NeuMe says its product is at Technology Readiness Level 5 and is still being validated, for stroke, brain injury and neurodegenerative patients.
NeuMe Neurotech, a Kozhikode-based deeptech startup, has received the first investment from the IvyCap Ventures India Endowment Fund, Sahyadri Startups reported on November 19. The amount was not disclosed. It is also NeuMe’s first investment since the company was incorporated in September 2025.
The deal was presented at Huddle Global 2026, the Kerala Startup Mission’s festival held in Kovalam from November 12 to 14. On the second day, IvyCap founder and managing partner Vikram Gupta closed his keynote by handing the stage to NeuMe founder Aparna RVM, calling NeuMe the first investment from the endowment he has been championing, e27 reported.
What NeuMe Neurotech Is Building
NeuMe combines a non-invasive BCI headband with adaptive, game-based software for cognitive rehabilitation, according to its Kerala Startup Mission profile. The system monitors brain activity in real time and tailors therapy for people recovering from stroke or traumatic brain injury, and for people with neurodegenerative conditions.
It plans to serve clinics and home users on a product-as-a-service model. The company says the product is at Technology Readiness Level 5 and is being validated, according to Sahyadri Startups. At that level, a technology has been tested in a relevant setting but is not yet a finished product.
Aparna RVM holds a master’s degree in cognitive science from IIT Delhi and a physics degree from Miranda House, and has worked with the I-Hub Foundation for Cobotics at IIT Delhi and as a data scientist, Sahyadri Startups reported. NeuMe’s website says the idea came from her mother’s stroke: her mother learned to walk again, but did not recognise her husband.
Also read
What the IvyCap Endowment Is
The India Endowment Fund channels returns from IvyCap’s venture capital business into research, innovation and entrepreneurship. Under IvyCap’s model, part of the profits from its funds goes to the alma maters of its investors, Sahyadri Startups reported.
Gupta set up India’s first endowment fund at IIT Delhi in 2019, e27 noted. At Huddle Global 2025, he argued that Kerala’s large diaspora could back a professionally managed endowment as a long-term pool of startup capital, Channel IAM reported at the time.
Huddle Global 2026 ended with investment announcements worth ₹8 crore, UNI reported. StartupFeed has covered two other deals from the event: Tessat Space’s ₹1 crore angel round and Bustler’s ₹50 lakh seed commitment.
What this means for you
If you are building deeptech or healthtech at the research stage, endowment-style funds are a new door to knock on, because they are designed to recycle returns into research and early ventures. Ask about cheque size, how decisions are made and what the fund expects back, since IvyCap has not disclosed these details. And if you are building a medical device, plan early for clinical validation and approvals; NeuMe is still at the validation stage.
StartupFeed Insight
Two things make this small deal worth watching. The money comes from an endowment built from venture profits rather than a regular fund, a model Gupta first used at IIT Delhi. If it works, it could give research-heavy startups patient early capital, which is hard to find. And NeuMe is a Kozhikode company building medical neurotechnology, outside the metro hubs where most deeptech money goes. e27 pointed out that one investment is not yet a track record, and the endowment’s size, governance and return expectations have not been made public. NeuMe’s own test is harder: turning a BCI rehab system at Technology Readiness Level 5 into something clinics will pay for needs clinical evidence, regulatory approval and a care model that works at home. Watch for the endowment’s size, its next investments and NeuMe’s first clinical pilot.
By Harshvardhan Kothari, Technology and Policy Correspondent
Have a tip? Write to us at editorial@startupfeed.in.
